Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy.
Animals
Antineoplastic Agents
/ chemistry
Benzene Derivatives
/ chemistry
Cell Line
Humans
Hydrogels
/ chemistry
Melanoma, Experimental
/ drug therapy
Mice
Nanocapsules
/ chemistry
Organoselenium Compounds
/ chemistry
Permeability
/ drug effects
Polymers
/ chemistry
Polysaccharides, Bacterial
/ chemistry
Cutaneous delivery
Nano-based hydrogels
Nanoparticles
SK-Mel-103
Selenium
Skin cancer
Journal
Investigational new drugs
ISSN: 1573-0646
Titre abrégé: Invest New Drugs
Pays: United States
ID NLM: 8309330
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
07
02
2019
accepted:
18
06
2019
pubmed:
3
7
2019
medline:
2
6
2021
entrez:
3
7
2019
Statut:
ppublish
Résumé
The aim of this study was to further evaluate the antitumoral effect of (PhSe)
Identifiants
pubmed: 31264068
doi: 10.1007/s10637-019-00823-2
pii: 10.1007/s10637-019-00823-2
doi:
Substances chimiques
Antineoplastic Agents
0
Benzene Derivatives
0
Hydrogels
0
Nanocapsules
0
Organoselenium Compounds
0
Polymers
0
Polysaccharides, Bacterial
0
diphenyldiselenide
1666-13-3
xanthan gum
TTV12P4NEE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM